Login / Signup

Waiting for Godot: Anticipating answers on embolic protection unlikely to arrive.

Khalil AnoutiWilliam A Gray
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
For symptomatic and asymptomatic patient with high or intermediate risk of CEA complications, CAS with the use of EPDs has a very low rate of in-hospital stroke and death There is no statistically significant difference in ipsilateral stroke/TIA and any stroke/TIA between the different device platforms Further efforts to assess differences between EPD devices would likely need to involve a surrogate endpoint due to the very low rates of clinical events.
Keyphrases
  • atrial fibrillation
  • crispr cas
  • healthcare
  • case report
  • emergency department
  • cerebral ischemia
  • risk factors
  • genome editing
  • quality improvement
  • adverse drug
  • drug induced